Articles Related to Ovarian Carcinoma
An Observational Chart Review of a Comparison of Generic to Reference Liposome-Encapsulated Doxorubicin Hydrochloride in Subjects with Epithelial Ovarian Carcinoma Who Have Failed Platinum-Based Chemotherapy
This study tested for the effects of generic liposome-encapsulated doxorubicin hydrochloride (generic doxorubicin) compared to reference-pegylated liposomal doxorubicin hydrochloride (reference doxorubicin) as a treatment for patients afflicted with epithelial ovarian carcinoma whose disease has progressed after platinum-based chemotherapy. Chart-reviews of actual patients enrolled in a community-based NIH trial suggest that both generic and reference liposomal doxorubicin hydrochloride (HCl) are equally effective
as treatment for ovarian cancer carcinoma.
Editorial Board Members Related to Ovarian Carcinoma
Steve A. Maxwell
Associate Professor
Department of Molecular and Cellular Medicine
Texas A&M Health Science Center
United States
Department of Molecular and Cellular Medicine
Texas A&M Health Science Center
United States